The activated pancreatic stellate cells of patients with pancreatic cancer express high levels of autophagy markers, extracellular matrix (ECM) proteins and interleukin-6 (IL-6), and the greater production of these proteins is associated with worse prognosis, shorter survival and higher risk of recurrence 14, 15. This evidence concerns the gene IL6 and familial pancreatic carcinoma.